Woodley BioReg has grown consistently and is now headquartered in Huddersfield, Yorkshire and staffed with highly qualified and experienced industry professionals working on projects throughout the UK and internationally. WBR has offices in China, Poland, India and USA, and partner groups in Italy and South Korea.
Woodley BioReg helps pharmaceutical, biopharmaceutical, healthcare, and medical device companies develop and manufacture quality products that are effective and safe for patients worldwide. We provide best-in-class scientific advice and consulting services in regulatory affairs, quality, clinical/nonclinical, and project management for all stages of product development.
Woodley BioReg helps pharmaceutical, biopharmaceutical, healthcare, and medical device companies develop and manufacture quality products that are effective and safe for patients worldwide. We provide best-in-class scientific advice and consulting services in regulatory affairs, quality, clinical/nonclinical, and project management for all stages of product development.
Services
The pharmaceutical industry includes products borne out of drug discovery programmes, extensions to existing product lines, longstanding brand lines and generics, and prescription-only-medicines. A major challenge for the pharmaceutical industry is the long and risky development process for new drugs; this is costly and can take over ten years from the laboratory to clinical trials.
Medical devices, drug delivery devices, and in vitro diagnostics include a wide range of products, such as inhalers, dressings, orthopaedic implants, invasive surgical devices and drug eluting stents, blood glucose meters, test kits, and many more.
These types of products are classified as active and non-active implantable medical devices andin vitrodiagnostic medical devices, whereby the classification depends on the potential risk to the patient.This in turn dictates the type of legislation required. The legislation strives to ensure that devices achieve a mandatory safety standard.
These types of products are classified as active and non-active implantable medical devices andin vitrodiagnostic medical devices, whereby the classification depends on the potential risk to the patient.This in turn dictates the type of legislation required. The legislation strives to ensure that devices achieve a mandatory safety standard.
Healthcare products include over-the-counter (OTC) medicines, some cosmetic products, herbal medicines, and nutraceuticals such as vitamins and supplements. Although the sector also includes many household brands that are readily available in supermarkets and pharmacies, it is important to note that they are subject to the same regulatory and quality control measures as other pharmaceutical products.
A career at Woodley BioReg is like no other. No two days are the same, as we get to work on exciting client projects globally. If you are interested in a career in regulatory affairs, please apply for one of the positions listed below. Regulatory Affairs, Non-clinical / Toxicology, Clinical experts are sought with 5 to 15+ years' experience working in the pharmaceutical, biologics / vaccines and medical device sectors.
Pharmaceutical companies typically manufacture at laboratory bench and pilot-scale for preliminarypreclinicaland toxicology studies and on occasion for phase Iclinical trials. As more product is required to support phase II and phase IIIclinical studies, the manufacturing operations need to be scaled-up and prepared for process validation.
Reviews
Be the first to review Woodley BioReg.
Write a Review
